|Study Description:||The goal of this clinical research study is to learn if an investigational |
therapy including fludarabine, cytarabine, G-CSF (filgrastim), a donor's NK
cells, and ALT-801 can be given reliably and safely in patients with AML. NK
cells are a type of white blood cell that fights infection and cancer.
Your leftover NK cells from the leukapheresis procedures will be tested to help
show how the infused NK cells may grow, survive, and function in the